ID   CY24B_MOUSE             Reviewed;         570 AA.
AC   Q61093;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 168.
DE   RecName: Full=Cytochrome b-245 heavy chain;
DE            EC=1.-.-.-;
DE   AltName: Full=CGD91-phox;
DE   AltName: Full=Cytochrome b(558) subunit beta;
DE            Short=Cytochrome b558 subunit beta;
DE   AltName: Full=Heme-binding membrane glycoprotein gp91phox;
DE   AltName: Full=Neutrophil cytochrome b 91 kDa polypeptide;
DE   AltName: Full=gp91-1;
DE   AltName: Full=gp91-phox;
DE   AltName: Full=p22 phagocyte B-cytochrome;
GN   Name=Cybb {ECO:0000312|MGI:MGI:88574}; Synonyms=Cgd;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8634451;
RA   Bjorgvinsdottir H., Zhen L., Dinauer M.C.;
RT   "Cloning of murine gp91phox cDNA and functional expression in a human X-
RT   linked chronic granulomatous disease cell line.";
RL   Blood 87:2005-2010(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NMRI; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [4]
RP   INTERACTION WITH NRROS, AND FUNCTION.
RX   PubMed=24739962; DOI=10.1038/nature13152;
RA   Noubade R., Wong K., Ota N., Rutz S., Eidenschenk C., Valdez P.A., Ding J.,
RA   Peng I., Sebrell A., Caplazi P., Devoss J., Soriano R.H., Sai T., Lu R.,
RA   Modrusan Z., Hackney J., Ouyang W.;
RT   "NRROS negatively regulates reactive oxygen species during host defence and
RT   autoimmunity.";
RL   Nature 509:235-239(2014).
RN   [5]
RP   UBIQUITINATION AT LYS-159; LYS-161; LYS-255; LYS-294; LYS-299; LYS-306;
RP   LYS-328; LYS-334; LYS-381; LYS-506 AND LYS-567.
RX   PubMed=26194095; DOI=10.1038/ncomms8838;
RA   Graham D.B., Becker C.E., Doan A., Goel G., Villablanca E.J., Knights D.,
RA   Mok A., Ng A.C., Doench J.G., Root D.E., Clish C.B., Xavier R.J.;
RT   "Functional genomics identifies negative regulatory nodes controlling
RT   phagocyte oxidative burst.";
RL   Nat. Commun. 6:7838-7838(2015).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND SUBCELLULAR LOCATION.
RX   PubMed=28351984; DOI=10.1084/jem.20161382;
RA   Thomas D.C., Clare S., Sowerby J.M., Pardo M., Juss J.K., Goulding D.A.,
RA   van der Weyden L., Storisteanu D., Prakash A., Espeli M., Flint S.,
RA   Lee J.C., Hoenderdos K., Kane L., Harcourt K., Mukhopadhyay S., Umrania Y.,
RA   Antrobus R., Nathan J.A., Adams D.J., Bateman A., Choudhary J.S.,
RA   Lyons P.A., Condliffe A.M., Chilvers E.R., Dougan G., Smith K.G.;
RT   "Eros is a novel transmembrane protein that controls the phagocyte
RT   respiratory burst and is essential for innate immunity.";
RL   J. Exp. Med. 214:1111-1128(2017).
CC   -!- FUNCTION: Critical component of the membrane-bound oxidase of
CC       phagocytes that generates superoxide. It is the terminal component of a
CC       respiratory chain that transfers single electrons from cytoplasmic
CC       NADPH across the plasma membrane to molecular oxygen on the exterior.
CC       Also functions as a voltage-gated proton channel that mediates the H(+)
CC       currents of resting phagocytes. {ECO:0000269|PubMed:24739962}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000305};
CC   -!- SUBUNIT: Composed of a heavy chain (beta) and a light chain (alpha).
CC       Component of an NADPH oxidase complex composed of a heterodimer formed
CC       by the membrane proteins CYBA and CYBB and the cytosolic subunits NCF1,
CC       NCF2 and NCF4. Interacts with NCF1. Interacts with calprotectin
CC       (S100A8/9) (By similarity). Interacts with NRROS; the interaction is
CC       direct and impairs formation of a stable NADPH oxidase complex
CC       (PubMed:24739962). Interacts with CYBC1; CYBC1 may act as a chaperone
CC       stabilizing Cytochrome b-245 heterodimer (By similarity).
CC       {ECO:0000250|UniProtKB:P04839, ECO:0000269|PubMed:24739962}.
CC   -!- INTERACTION:
CC       Q61093; Q61462: Cyba; NbExp=4; IntAct=EBI-6654585, EBI-15795776;
CC       Q61093; Q8BMT4: Nrros; NbExp=4; IntAct=EBI-6654585, EBI-16102695;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=As unassembled monomer may localize to the endoplasmic reticulum.
CC       {ECO:0000305|PubMed:28351984}.
CC   -!- PTM: Glycosylated.
CC   -!- PTM: Phosphorylated on Ser and Thr residues. {ECO:0000250}.
CC   -!- PTM: Undergoes 'Lys-48'-linked polyubiquitination, likely by RNF145,
CC       triggering endoplasmic reticulum-associated degradation.
CC       {ECO:0000269|PubMed:26194095}.
CC   -!- DISRUPTION PHENOTYPE: Mutants have a very sever defect in controlling
CC       bacterial replication. {ECO:0000269|PubMed:28351984}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U43384; AAB05997.1; -; mRNA.
DR   EMBL; BC071229; AAH71229.1; -; mRNA.
DR   CCDS; CCDS30010.1; -.
DR   RefSeq; NP_031833.3; NM_007807.5.
DR   RefSeq; XP_006527628.1; XM_006527565.3.
DR   SMR; Q61093; -.
DR   BioGRID; 198990; 29.
DR   DIP; DIP-60841N; -.
DR   IntAct; Q61093; 5.
DR   STRING; 10090.ENSMUSP00000015484; -.
DR   PeroxiBase; 5957; MmNOx02.
DR   GlyGen; Q61093; 1 site.
DR   iPTMnet; Q61093; -.
DR   PhosphoSitePlus; Q61093; -.
DR   SwissPalm; Q61093; -.
DR   jPOST; Q61093; -.
DR   MaxQB; Q61093; -.
DR   PaxDb; Q61093; -.
DR   PRIDE; Q61093; -.
DR   ProteomicsDB; 285357; -.
DR   Antibodypedia; 24864; 499 antibodies.
DR   Ensembl; ENSMUST00000015484; ENSMUSP00000015484; ENSMUSG00000015340.
DR   GeneID; 13058; -.
DR   KEGG; mmu:13058; -.
DR   UCSC; uc009spv.3; mouse.
DR   CTD; 1536; -.
DR   MGI; MGI:88574; Cybb.
DR   eggNOG; KOG0039; Eukaryota.
DR   GeneTree; ENSGT00940000160244; -.
DR   HOGENOM; CLU_005646_3_1_1; -.
DR   InParanoid; Q61093; -.
DR   OMA; GHVMLLC; -.
DR   OrthoDB; 936110at2759; -.
DR   PhylomeDB; Q61093; -.
DR   TreeFam; TF105354; -.
DR   Reactome; R-MMU-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-MMU-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-MMU-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-MMU-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-MMU-5668599; RHO GTPases Activate NADPH Oxidases.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 13058; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Cybb; mouse.
DR   PRO; PR:Q61093; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; Q61093; protein.
DR   Bgee; ENSMUSG00000015340; Expressed in mesenteric lymph node and 158 other tissues.
DR   ExpressionAtlas; Q61093; baseline and differential.
DR   Genevisible; Q61093; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0043020; C:NADPH oxidase complex; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0005635; C:nuclear envelope; ISO:MGI.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISO:MGI.
DR   GO; GO:0020037; F:heme binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI.
DR   GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IDA:MGI.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0071361; P:cellular response to ethanol; IEA:Ensembl.
DR   GO; GO:1904845; P:cellular response to L-glutamine; IEA:Ensembl.
DR   GO; GO:0006952; P:defense response; IBA:GO_Central.
DR   GO; GO:0022900; P:electron transport chain; IEA:GOC.
DR   GO; GO:0050665; P:hydrogen peroxide biosynthetic process; IMP:MGI.
DR   GO; GO:0097411; P:hypoxia-inducible factor-1alpha signaling pathway; ISO:MGI.
DR   GO; GO:0006954; P:inflammatory response; IMP:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IMP:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:MGI.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:MGI.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0045730; P:respiratory burst; ISO:MGI.
DR   GO; GO:1904044; P:response to aldosterone; IEA:Ensembl.
DR   GO; GO:1990776; P:response to angiotensin; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; ISO:MGI.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0042554; P:superoxide anion generation; ISO:MGI.
DR   GO; GO:0006801; P:superoxide metabolic process; IMP:UniProtKB.
DR   Gene3D; 3.40.50.80; -; 1.
DR   InterPro; IPR000778; Cyt_b245_heavy_chain.
DR   InterPro; IPR013112; FAD-bd_8.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR013121; Fe_red_NAD-bd_6.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF08022; FAD_binding_8; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   Pfam; PF08030; NAD_binding_6; 1.
DR   PRINTS; PR00466; GP91PHOX.
DR   SUPFAM; SSF52343; SSF52343; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Electron transport; FAD; Flavoprotein; Glycoprotein; Heme;
KW   Ion channel; Ion transport; Iron; Isopeptide bond; Membrane; Metal-binding;
KW   NADP; Oxidoreductase; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation; Voltage-gated channel.
FT   CHAIN           1..570
FT                   /note="Cytochrome b-245 heavy chain"
FT                   /id="PRO_0000210146"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..48
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        49..69
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        70..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..169
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        170..190
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        191..200
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        201..221
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        222..261
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        262..282
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        283..570
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          54..286
FT                   /note="Ferric oxidoreductase"
FT   DOMAIN          287..397
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   NP_BIND         338..344
FT                   /note="FAD"
FT                   /evidence="ECO:0000255"
FT   METAL           101
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000305"
FT   METAL           115
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000305"
FT   METAL           209
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000305"
FT   METAL           222
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        40
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        159
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        161
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        255
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        294
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        299
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        306
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        334
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        381
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        506
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
FT   CROSSLNK        567
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:26194095"
SQ   SEQUENCE   570 AA;  65305 MW;  8816274E3D253DFA CRC64;
     MGNWAVNEGL SIFVILVWLG LNVFLFINYY KVYDDGPKYN YTRKLLGSAL ALARAPAACL
     NFNCMLILLP VCRNLLSFLR GSSACCSTRI RRQLDRNLTF HKMVAWMIAL HTAIHTIAHL
     FNVEWCVNAR VGISDRYSIA LSDIGDNENE EYLNFAREKI KNPEGGLYVA VTRLAGITGI
     VITLCLILII TSSTKTIRRS YFEVFWYTHH LFVIFFIGLA IHGAERIVRG QTAESLEEHN
     LDICADKIEE WGKIKECPVP KFAGNPPMTW KWIVGPMFLY LCERLVRFWR SQQKVVITKV
     VTHPFKTIEL QMKKKGFKME VGQYIFVKCP KVSKLEWHPF TLTSAPEEDF FSIHIRIVGD
     WTEGLFNACG CDKQEFQDAW KLPKIAVDGP FGTASEDVFS YEVVMLVGAG IGVTPFASIL
     KSVWYKYCDN ATSLKLKKIY FYWLCRDTHA FEWFADLLQL LETQMQERNN ANFLSYNIYL
     TGWDESQANH FAVHHDEEKD VITGLKQKTL YGRPNWDNEF KTIASEHPNT TIGVFLCGPE
     ALAETLSKQS ISNSESGPRG VHFIFNKENF
//
